Top Markets
#1 Siren Siren +38.80%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#3 Ocean Protocol Ocean Protocol +17.20%
#4 KUB Coin KUB Coin +14.89%
#5 Audiera Audiera +11.92%
#6 Perle Perle +10.80%
#7 Arowana Arowana +9.87%
#8 Geodnet Geodnet +9.30%
#9 Nockchain Nockchain +8.82%
#10 Wiki Cat Wiki Cat +8.40%
Coin of the day
Siren Siren
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Rang în acțiuni #32249
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Preț acțiune
$0.8013
Ultima sincronizare: 2026-08-05
Capitalizare de piață
$10.62M
Schimbare (1 zi)
0.97%
Schimbare (1 an)
-37.88%
Țară
US
Tranzacționează Hoth Therapeutics, Inc. (HOTH)

Categorie

Healthcare
Raport P/B pentru Hoth Therapeutics, Inc. (HOTH)
Raport P/B la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Hoth Therapeutics, Inc., raportul P/B actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/B de 0.
Istoricul raportului P/B pentru Hoth Therapeutics, Inc. din 2026 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR